Author

Vesna Prchkovska

Act Now to Perform Retrospective Analysis of Past Phase II, III Alzheimer’s Clinical Trials

Act Now to Perform Retrospective Analysis of Past Phase II, III Alzheimer’s Clinical Trials

By Vesna Prchkovska | News, Expertise, Alzheimer

A Landmark FDA Approval For Alzheimer’s Shakes Up Industry On June 7th, 2021, accelerated regulatory approval was granted for Alzheimer’s drug, Aduhelm (aducanumab), designed to slow cognitive...

Neuroimaging Based Clinical Trials are Failing. How Can You Fix Them?

Neuroimaging Based Clinical Trials are Failing. How Can You Fix Them?

By Vesna Prchkovska | Expertise

There is a huge unmet need in treating patients with brain diseases; clinical trials fail and finding effective therapies is hard. If your company is struggling or failing with its...